ApprovalTrail

Approval · Notice of Compliance 622 · 2002

IBUPROFEN: Notice of Compliance 622

Issued February 14, 2002

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
622
Date
February 14, 2002
Company
Vita Health Products Inc.Winnipeg, Manitoba, Canada
Product type
Nonprescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer name change
Therapeutic class
Analgesic, antipyretic

Products in this notice

BrandDINStatus today
IBUPROFEN02238004Cancelled Post Market

Medicinal ingredients